Literature DB >> 9651354

Differential interactions of the C terminus and the cytoplasmic I-II loop of neuronal Ca2+ channels with G-protein alpha and beta gamma subunits. II. Evidence for direct binding.

T Furukawa1, R Miura, Y Mori, M Strobeck, K Suzuki, Y Ogihara, T Asano, R Morishita, M Hashii, H Higashida, M Yoshii, T Nukada.   

Abstract

The present study was designed to obtain evidence for direct interactions of G-protein alpha (Galpha) and beta gamma subunits (Gbeta gamma) with N- (alpha1B) and P/Q-type (alpha1A) Ca2+ channels, using synthetic peptides and fusion proteins derived from loop 1 (cytoplasmic loop between repeat I and II) and the C terminus of these channels. For N-type, prepulse facilitation as mediated by Gbeta gamma was impaired when a synthetic loop 1 peptide was applied intracellularly. Receptor agonist-induced inhibition of N-type as mediated by Galpha was also impaired by the loop 1 peptide but only when applied in combination with a C-terminal peptide. For P/Q-type channels, by contrast, the Galpha-mediated inhibition was diminished by application of a C-terminal peptide alone. Moreover, in vitro binding analysis for N- and P/Q-type channels revealed direct interaction of Galpha with C-terminal fusion proteins as well as direct interaction of Gbeta gamma with loop 1 fusion proteins. These findings define loop 1 of N- and P/Q-type Ca2+ channels as an interaction site for Gbeta gamma and the C termini for Galpha.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9651354     DOI: 10.1074/jbc.273.28.17595

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Multiple G-protein betagamma combinations produce voltage-dependent inhibition of N-type calcium channels in rat superior cervical ganglion neurons.

Authors:  V Ruiz-Velasco; S R Ikeda
Journal:  J Neurosci       Date:  2000-03-15       Impact factor: 6.167

2.  Functional expression and FRET analysis of green fluorescent proteins fused to G-protein subunits in rat sympathetic neurons.

Authors:  V Ruiz-Velasco; S R Ikeda
Journal:  J Physiol       Date:  2001-12-15       Impact factor: 5.182

3.  The C terminus of the Ca channel alpha1B subunit mediates selective inhibition by G-protein-coupled receptors.

Authors:  A A Simen; C C Lee; B B Simen; V P Bindokas; R J Miller
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

4.  G-protein inhibition of N- and P/Q-type calcium channels: distinctive elementary mechanisms and their functional impact.

Authors:  H M Colecraft; D L Brody; D T Yue
Journal:  J Neurosci       Date:  2001-02-15       Impact factor: 6.167

5.  Involvement of protein kinase C and protein kinase A in the enhancement of L-type calcium current by GABAB receptor activation in neonatal hippocampus.

Authors:  J G Bray; M Mynlieff
Journal:  Neuroscience       Date:  2011-01-28       Impact factor: 3.590

6.  Differential occurrence of reluctant openings in G-protein-inhibited N- and P/Q-type calcium channels.

Authors:  H M Colecraft; P G Patil; D T Yue
Journal:  J Gen Physiol       Date:  2000-02       Impact factor: 4.086

Review 7.  Low-voltage-activated ("T-Type") calcium channels in review.

Authors:  Anne Marie R Yunker; Maureen W McEnery
Journal:  J Bioenerg Biomembr       Date:  2003-12       Impact factor: 2.945

Review 8.  GPCR mediated regulation of synaptic transmission.

Authors:  Katherine M Betke; Christopher A Wells; Heidi E Hamm
Journal:  Prog Neurobiol       Date:  2012-01-28       Impact factor: 11.685

9.  A region of the sulfonylurea receptor critical for a modulation of ATP-sensitive K(+) channels by G-protein betagamma-subunits.

Authors:  Y Wada; T Yamashita; K Imai; R Miura; K Takao; M Nishi; H Takeshima; T Asano; R Morishita; K Nishizawa; S Kokubun; T Nukada
Journal:  EMBO J       Date:  2000-09-15       Impact factor: 11.598

Review 10.  G-protein signaling: back to the future.

Authors:  C R McCudden; M D Hains; R J Kimple; D P Siderovski; F S Willard
Journal:  Cell Mol Life Sci       Date:  2005-03       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.